Repoxygen

Repoxygen2016-11-15T13:52:25+00:00

Repoxygen

MOLECULAR MEDICINE

proprietary–Oxford Biomedica–gene therapy which provides controlled release of erythropoietin–EPO in response to low O2 concentration in patients with chronic, treatment-refractory anaemia.

It is packaged as a viral delivery vector* with the EPO gene under hypoxia-inducible factors–HIF-responsive element–HRE control. HRE senses low oxygen concentrations and switch on the EPO gene. 

*Because Repoxgen’s protein is of viral origin, it could evoke a potentially fatal immune response. Repoxygen has the potential for abuse by endurance athletes, but may be of use for “anoxic” sports, including high mountain climbing and deep free diving.

Reference http://en.wikipedia.org/wiki/Repoxygen

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.